Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1193.0000 10.00 (0.85%)
NSE Jan 01, 2026 15:31 PM
Volume: 412.1K
 

1193.00
0.85%
Sharekhan
Quarterly revenue reached Rs. 7,796 crore, up 8% y-o-y and 3% q-o-q, exceeding our estimates by 1%, while PAT was Rs. 817 crore, showing a 9% y-o-y increase but an 11% q-o-q decrease, falling 19% below our estimates.
Promoters pledged 0.42% of shares in last quarter. Total pledge stands at 17.50% of promoter holdings
More from Aurobindo Pharma Ltd.
Recommended